Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
The Business of Pediatric Dermatology: Challenges and Successes
Description
The presentation addresses the business dynamics and challenges faced in pediatric dermatology, particularly in academic settings where most practitioners work. The speaker highlights a workforce shortage, with only 5.7 pediatric dermatologists per million children, exacerbated by disparities in pay structures between pediatrics and dermatology, leading many potential candidates away from the specialty. The financial strains on pediatric hospitals stem from various factors, including a rising number of patients with chronic illnesses and a growing mental health crisis, which complicate bed availability and resource allocation. Additionally, the speaker discusses systemic inefficiencies, such as the burden of prior authorizations for treatments and the increasing costs of new biologics, which, while beneficial, strain hospital budgets. The economic landscape is fraught with pressures to maximize patient throughput while ensuring quality care, resulting in burnout among practitioners. Efforts to improve efficiency, including better scheduling practices and leveraging data management systems, are underway to tackle these challenges. Lastly, recent advancements in treatment, such as new FDA-approved drugs, come with high costs, raising concerns over sustainability and equitable access to care.
View moreConclusions
- Pediatric dermatology faces significant economic challenges due to reliance on academic settings and lower pediatric pay structures.
- There is a workforce shortage of pediatric dermatologists, highlighted by an average of only 5.7 pediatric dermatologists per million children in the US.
- The pipeline for training new pediatric dermatologists is inadequate, with less than 20 new fellowship-trained specialists entering the field per year.
- Many pediatric dermatologists report burnout, with around 25% experiencing significant stress or exhaustion.
- The current economic model for pediatric dermatology is unsustainable, exacerbating the workforce shortage issues.
- Increasing efficiency in clinics is essential to managing patient loads and improving service delivery.
- High costs associated with new therapies, such as biologics for atopic dermatitis, may strain healthcare budgets and affect access to treatments.
- Recent FDA approvals for pediatric drugs have implications for economic considerations and access, indicating that approval does not guarantee availability.
- There is a need for innovative solutions and collaborations, like the Edvyce platform, to address gaps in pediatric dermatology services.
- Overall, both hospital economics and workforce shortages threaten the future of pediatric dermatology.
- Khorsand K, Sidbury R. The 'Shadow Clinic' --- Emails, curbsides, and quick peeks in pediatric dermatology. Pediatr Dermatol 2019;36(5):607-610
- Dhillon S. Beremagene geperpavec: first approval. Drugs 2023;83(12)1131-35